US passes thyroid cancer drug

UK pharmaceutical company AstraZeneca has had a new drug to treat thyroid cancer approved by the US Food and Drug Administration. The drug is called Vandetanib, and is a daily oral pill to treat adult patients with a rare form of thyroid cancer who are getting sicker and are not candidates for surgery. AstraZeneca runs an oncology and infectious diseases centre in Massachusetts.